Constructive Bio announces its launch as a new UK-based biotechnology company following the completion of a $15m seed round and an exclusive license from the Medical Research Council (MRC), to IP developed by Professor Jason Chin’s Laboratory (Chin Lab) at the MRC Laboratory of Molecular Biology (MRC-LMB).














